{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Medsider: Learn from Medtech and Healthtech Founders and CEOs","title":"The Art of Medical Device Reimbursement: Interview with Randel Richner, Founder of Neocure Group","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/e8b7cf91\"></iframe>","width":"100%","height":180,"duration":1993,"description":"This interview is a continuation of a throwback mini-series that I’ve been releasing over the past few weeks with some of my favorite Medsider guests of all time.\nOn this particular episode, I chatted with Randel Richner, a true expert when it comes to healthcare economics and reimbursement.  At the time of this interview, she was with Neocure Group, a company she founded and later sold to Intralign.\nAlthough this discussion is several years old and the audio quality isn’t ideal, the insights Randel provides are timeless. Here are some of the thing we covered:\nA case study of how Randel helped save a medical device company from severe reimbursement implications.\nRandel’s unique “orchestra score” philosophy and how it aids in streamlining reimbursement strategies.\nThe importance of defining the difference between how hospitals get paid and how physicians get paid.\nAnd what Randel means by the statement “comparative effectiveness is a code word for cost-effectiveness”.\nSee more...","thumbnail_url":"https://img.transistorcdn.com/GgkwQ6SZM6b2rlIWqV8q-HUOooXOpwR2mZVZnhA1EYA/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzM2MTYwLzE2OTUx/MzY5NjUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}